Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Alkylphosphocholines: a new class of membrane-active anticancer agents.

× No keyword cloud information.

20 in total

1. Experimental therapeutic studies with miltefosine in rats and mice.

Authors: P Hilgard; J Stekar; R Voegeli; J H Harleman
Journal: Prog Exp Tumor Res Date: 1992

2. Specific interaction between phosphatidylinositol 4,5-bisphosphate and profilactin.

Authors: I Lassing; U Lindberg
Journal: Nature Date: 1985 Apr 4-10 Impact factor: 49.962

3. The specific inhibitor of protein kinase C, 1-(5-isoquinolinylsulfonyl)-2-methylpiperazine (H7), induces morphological change and cell differentiation of human neural crest-derived cell lineages.

Authors: M T Parodi; L Varesio; G P Tonini
Journal: FEBS Lett Date: 1990-08-20 Impact factor: 4.124

4. Effects of antineoplastic phospholipids on parameters of cell differentiation in U937 cells.

Authors: C Hochhuth; D Berkovic; H Eibl; C Unger; D Doenecke
Journal: J Cancer Res Clin Oncol Date: 1990 Impact factor: 4.553

5. Inhibition of protein kinase C induces differentiation in Neuro-2a cells.

Authors: M D Miñana; V Felipo; S Grisolía
Journal: Proc Natl Acad Sci U S A Date: 1990-06 Impact factor: 11.205

6. Hexadecylphosphocholine: determination of serum concentrations in rats.

Authors: C Unger; E Fleer; W Damenz; P Hilgard; G Nagel; H Eibl
Journal: J Lipid Mediat Date: 1991 Jan-Feb

7. Hexadecylphosphocholine stimulates the colony-stimulating factor-dependent growth of hemopoietic progenitor cells.

Authors: K Vehmeyer; H Eibl; C Unger
Journal: Exp Hematol Date: 1992-01 Impact factor: 3.084

8. Alkyl phosphocholines: toxicity and anticancer properties.

Authors: C Muschiol; M R Berger; B Schuler; H R Scherf; F T Garzon; W J Zeller; C Unger; H J Eibl; D Schmähl
Journal: Lipids Date: 1987-11 Impact factor: 1.880

9. Characterization of the antitumor activity of hexadecylphosphocholine (D 18506).

Authors: P Hilgard; J Stekar; R Voegeli; J Engel; W Schumacher; H Eibl; C Unger; M R Berger
Journal: Eur J Cancer Clin Oncol Date: 1988-09

10. Hexadecylphosphocholine inhibits translocation of CTP:choline-phosphate cytidylyltransferase in Madin-Darby canine kidney cells.

Authors: C C Geilen; T Wieder; W Reutter
Journal: J Biol Chem Date: 1992-04-05 Impact factor: 5.157

17 in total

1. Proinflammatory and cytotoxic effects of hexadecylphosphocholine (miltefosine) against drug-resistant strains of Trypanosoma cruzi.

Authors: Victor B Saraiva; Daniel Gibaldi; José O Previato; Lucia Mendonça-Previato; Marcelo T Bozza; Célio G Freire-De-Lima; Norton Heise
Journal: Antimicrob Agents Chemother Date: 2002-11 Impact factor: 5.191

2. Tumor and normal tissue pharmacokinetics of perifosine, an oral anti-cancer alkylphospholipid.

Authors: Stefan R Vink; Jan H M Schellens; Wim J van Blitterswijk; Marcel Verheij
Journal: Invest New Drugs Date: 2005-08 Impact factor: 3.850

3. Perifosine , an oral, anti-cancer agent and inhibitor of the Akt pathway: mechanistic actions, pharmacodynamics, pharmacokinetics, and clinical activity.

Authors: Paul G Richardson; Cathy Eng; Jill Kolesar; Teru Hideshima; Kenneth C Anderson
Journal: Expert Opin Drug Metab Toxicol Date: 2012-05 Impact factor: 4.481

Alkylphosphocholines: a new class of membrane-active anticancer agents.

1. Experimental therapeutic studies with miltefosine in rats and mice.

2. Specific interaction between phosphatidylinositol 4,5-bisphosphate and profilactin.

3. The specific inhibitor of protein kinase C, 1-(5-isoquinolinylsulfonyl)-2-methylpiperazine (H7), induces morphological change and cell differentiation of human neural crest-derived cell lineages.

4. Effects of antineoplastic phospholipids on parameters of cell differentiation in U937 cells.

5. Inhibition of protein kinase C induces differentiation in Neuro-2a cells.

6. Hexadecylphosphocholine: determination of serum concentrations in rats.

7. Hexadecylphosphocholine stimulates the colony-stimulating factor-dependent growth of hemopoietic progenitor cells.

8. Alkyl phosphocholines: toxicity and anticancer properties.

9. Characterization of the antitumor activity of hexadecylphosphocholine (D 18506).

10. Hexadecylphosphocholine inhibits translocation of CTP:choline-phosphate cytidylyltransferase in Madin-Darby canine kidney cells.

1. Proinflammatory and cytotoxic effects of hexadecylphosphocholine (miltefosine) against drug-resistant strains of Trypanosoma cruzi.

2. Tumor and normal tissue pharmacokinetics of perifosine, an oral anti-cancer alkylphospholipid.

3. Perifosine , an oral, anti-cancer agent and inhibitor of the Akt pathway: mechanistic actions, pharmacodynamics, pharmacokinetics, and clinical activity.

4. Possible mechanism of miltefosine-mediated death of Leishmania donovani.

5. Evaluation of the effect of miltefosine on Trichomonas vaginalis.

6. Antineoplastic activity and tolerability of a novel heterocyclic alkylphospholipid, D-20133.

7. The effect of hexadecylphosphocholine on the degradation of mitochondrial phospholipids.

Review 8. Current concepts of treatment in medical oncology: new anticancer drugs.

9. Alkylphosphocholine-induced production of nitric oxide and tumor necrosis factor alpha by U 937 cells.

10. Effects of hexadecylphosphocholine on fatty acid metabolism: relation to cytotoxicity.